Differential cytotoxicity of tumour promoter TPA for EBV-negative human lymphoma cell lines and their EBV-converted sublines. | Int J Cancer;32(1): 61-5, 1983 Jul 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Differential cytotoxicity of tumour promoter TPA for EBV-negative human lymphoma cell lines and their EBV-converted sublines.

Béchet, J M; Guétard, D.

Int J Cancer ; 32(1): 61-5, 1983 Jul 15.

Article in En | MEDLINE | ID: mdl-6305854

Subject(s)

Cell Transformation, Viral; Herpesvirus 4, Human; Lymphoma/pathology; Phorbols/pharmacology; Tetradecanoylphorbol Acetate/pharmacology; Cell Division/drug effects; Cell Line; Dose-Response Relationship, Drug; Humans

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Phorbols / Tetradecanoylphorbol Acetate / Cell Transformation, Viral / Herpesvirus 4, Human / Lymphoma Limits: Humans Language: En Journal: Int J Cancer Year: 1983 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Phorbols / Tetradecanoylphorbol Acetate / Cell Transformation, Viral / Herpesvirus 4, Human / Lymphoma Limits: Humans Language: En Journal: Int J Cancer Year: 1983 Document type: Article Country of publication: United States